IN8BIO, INC. — Director's Dealing 2021

Jul 30, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-07-29

Reporting Person: Ho William Tai-Wei (Director, President, CEO and CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2289430	Direct
Common Stock	73000	Indirect
Common Stock	69929	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (3070)		Indirect
Employee Stock Option (right to buy)	$6.7398	2030-10-04	Common Stock (182500)		Direct

Footnotes

F1: The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.

F2: Each share of Series A Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, has no expiration date and is expected to automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.

F3: Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2021, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each
such date.